New Akt Inhibitors

Catalog No. Product Name Information
E5971 ZINC00640089 ZINC00640089 is a selective Lipocalin-2 (LCN2) inhibitor that suppresses cell proliferation, decreases cell viability, and reduces AKT phosphorylation levels in SUM149 cells. This compound shows promising research potential for inflammatory breast cancer (IBC) studies.
F4087 Phospho-Akt1 (Ser473) Antibody [K10L8]
E4992 Afuresertib hydrochloride Afuresertib hydrochloride (GSK 2110183 hydrochloride, LAE002 hydrochloride) is an orally bioavailable, selective, ATP-competitive and potent inhibitor of pan-Akt kinase with Ki values of 0.08 nM, 2 nM, 2.6 nM for Akt1/Akt2/Akt3 respectively.
E5820 AKT Kinase Inhibitor AKT Kinase Inhibitor is an inhibitor of Akt that reverses the protective effects of Tadalafil (TAD) in LPS-induced RWPE-1 cells by decreasing cell viability, promoting apoptosis, and increasing pro-inflammatory cytokine levels.
All Akt Inhibitors